$Brainchip Holdings Ltd.(BRCHF)$ $Taiwan Semiconductor Manufacturing(TSM)$ $iShares Semiconductor ETF(SOXX)$ $Direxion Daily Semiconductors Bull 3x Shares(SOXL)$
🧠 $BRAINCHIP HOLDINGS LTD - Neuromorphic AI Technology 🧠
BrainChip Holdings Ltd (ASX: BRN) is an Australian semiconductor company pioneering neuromorphic computing, which mimics the brain’s neural networks for highly efficient, low-power AI. This post looks objectively at BrainChip’s technology, key partnerships, its NASA contract, plans for the U.S. market, and why I believe it’s undervalued.
🧠 TECHNOLOGY OVERVIEW: AKIDA NEUROMORPHIC PROCESSOR 🧠
BrainChip’s flagship, the Akida™ processor, is built on spiking neural networks (SNNs), allowing event-driven AI processing that drastically reduces power use and latency. Unlike traditional AI chips, Akida can learn and make decisions in real time directly on the device. It’s ideal for applications in IoT, automotive, and security.
The second-gen AKD1500 processor adds support for 8-bit weights, a Vision Transformer engine, and Temporal Event-Based Neural Networks (TENN), pushing performance for complex edge AI tasks while staying power-efficient.
During the global chip shortage in began in 2020 and extended to 2022, many companies across industries faced severe production delays due to limited semiconductor supply. In the midst of this disruption, TSM (Taiwan Semiconductor Manufactoring Company) made the strategic decision to continue supplying BrainChip, underscoring the significance of Akida™️ neuromorphic processor.
📊 FINANCIAL SNAPSHOT (JUNE 2025) 📊
Market Cap: ~AUD 422 million
Revenue (TTM): AUD 608,210
Net Income (TTM): -AUD 37.3 million
Employees: 63 (as of 31 December 2024).
BrainChip remains pre-profit, focusing heavily on R&D to grow its tech and market footprint.
🤝 KEY PARTNERSHIPS & COLLABORATIONS 🤝
Intel Foundry Services: Produces Akida chips at scale using Intel’s advanced fabs—vital for ramping production.
NVISO: Integrated Akida into security & surveillance platforms, boosting its AI footprint.
Automotive pilots: Collaborating with automotive OEMs and Tier 1 suppliers on driver-assist and in-car AI. Details are often confidential.
Development Kits: Sold since 2021 to global developers and researchers, building a strong commercial pipeline.
Edge Impulse: Partnership lets developers deploy AI models on Akida easily, broadening adoption.
🚀 NASA CONTRACT — A MAJOR VALIDATION 🚀
BrainChip secured a contract with NASA to use Akida in space exploration and advanced AI projects. This highlights Akida’s reliability in extreme environments, providing huge credibility. NASA’s use of BrainChip’s tech positions it for future high-profile aerospace and government work.
🇺🇸 POTENTIAL U.S. MARKET MOVE 🇺🇸
In February 2025, BrainChip announced plans to explore redomiciling to the U.S. and listing on a major American exchange. This aims to attract deeper capital pools and raise global visibility. For now, it’s traded on the OTCQX (BRCHF), but a major listing could significantly broaden investor reach.
🧾 CONCLUSION 🧾
BrainChip is truly at the forefront of neuromorphic computing. Its Akida processor promises a leap in energy-efficient edge AI, validated by partnerships with Intel, NVISO, and NASA. Combined with its planned U.S. move, I see BrainChip as undervalued relative to its groundbreaking technology and global market potential - an intriguing opportunity for those investing in next-gen AI hardware.
Disclosure: DYOR.
Modify on 2025-07-23 00:32
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
